Search Within

Gopakumar Vasudeva Iyer

Formats
  1. Meeting Abstract (202)
  2. Journal Article (118)
  3. Review (11)
  4. Book Section (5)
  5. Editorial (3)
  6. Correspondence (2)
  7. Research Letter (1)
Groups
  1. Department of Medicine (342)
  2. Genitourinary Oncology Service (342)
  3. Solid Tumor Oncology Division (342)
  4. Department of Pathology and Laboratory Medicine (214)
  5. GSK Faculty (194)
  6. Human Oncology and Pathogenesis Program (191)

More Groups

People
  1. Hikmat Al-Ahmadie (182)
  2. David Solit (181)
  3. Jonathan Rosenberg (169)
  4. Dean Bajorin (160)
  5. Bernard Bochner (129)
  6. Michael Berger (102)

More People

Years
  1. 2025 (14)
  2. 2024 (41)
  3. 2023 (30)
  4. 2022 (33)
  5. 2021 (34)
  6. 2020 (22)

More Years

Publications
  1. Journal of Clinical Oncology (117)
  2. Laboratory Investigation (27)
  3. Modern Pathology (20)
  4. Cancer Research (17)
  5. Clinical Cancer Research (14)
  6. Annals of Oncology (13)

More Publications

Publishers
  1. American Society of Clinical Oncology (125)
  2. Nature Publishing Group (43)
  3. American Association for Cancer Research (34)
  4. Elsevier Inc. (33)
  5. Nature Research (20)
  6. Oxford University Press (15)

More Publishers

Results (342)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Recurrent novel and potentially targetable genetic alterations in high grade, invasive urothelial carcinoma of the bladder
    Meeting Abstract

    Al-Ahmadie, H. A.; Iyer, G.; Kim, P. H.; Sfakianos, J. P.; Chen, Y. B.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Bochner, B. H.; Bajorin, D. F.; more...
    Modern Pathology (2013)

    Fulltext@MSK | Save
  • Recurrent novel and potentially targetable genetic alterations in high grade, invasive urothelial carcinoma of the bladder
    Meeting Abstract

    Al-Ahmadie, H. A.; Iyer, G.; Kim, P. H.; Sfakianos, J. P.; Chen, Y. B.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Bochner, B. H.; Bajorin, D. F.; more...
    Laboratory Investigation (2013)

    Fulltext@MSK | Save
  • E-cadherin (CDH1) is frequently mutated in urothelial carcinoma with signet-ring cell and plasmacytoid morphology
    Meeting Abstract

    Al-Ahmadie, H.; Iyer, G.; Mehra, R.; Chen, Y.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Berger, M. F.; Bajorin, D. F.; Dalbagni, G.; more...
    Modern Pathology (2013)

    Fulltext@MSK | Save
  • E-Cadherin (CDH1) is frequently mutated in urothelial carcinoma with signet-ring cell and plasmacytoid morphology
    Meeting Abstract

    Al-Ahmadie, H.; Iyer, G.; Mehra, R.; Chen, Y.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Berger, M. F.; Bajorin, D. F.; Dalbagni, G.; more...
    Laboratory Investigation (2013)

    Fulltext@MSK | Save
  • Specific PPAR gamma agonists may have different effects on cancer incidence
    Journal Article

    Bambury, R. M.; Iyer, G.; Rosenberg, J. E.
    Annals of Oncology (2013)

    Fulltext@MSK | Save
  • Oncogenic activation of Pak1-dependent pathway of macropinocytosis determines BCG entry into bladder cancer cells
    Journal Article

    Redelman-Sidi, G.; Iyer, G.; Solit, D. B.; Glickman, M. S.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • BRAF Mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer
    Journal Article

    Grisham, R. N.; Iyer, G.; Garg, K.; DeLair, D.; Hyman, D. M.; Zhou, Q.; Iasonos, A.; Berger, M. F.; Dao, F.; Spriggs, D. R.; more...
    Cancer (2013)

    Fulltext@MSK | Save
  • Defining the genetic basis of everolimus sensitivity in metastatic bladder cancer (MBC) by whole-genome sequencing (WGS)
    Meeting Abstract

    Iyer, G.; Milowsky, M. I.; Al-Ahmadie, H.; Hanrahan, A.; Janakiraman, M.; Heguy, A.; Viale, A.; Socci, N. D.; Sander, C.; Bochner, B.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A comprehensive analysis of BRAF and KRAS mutation status in low-grade serous (LGS) and serous borderline (SB) ovarian cancer (OC)
    Meeting Abstract

    Grisham, R. N.; Garg, K.; Zhou, Q.; Iasonos, A.; Berger, M. F.; Dao, F.; Hyman, D. M.; Levine, D. A.; Solit, D. B.; Aghajanian, C.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of neoadjuvant gemcitabine (G) and cisplatin (C) with sunitinib in patients (pts) with muscle-invasive bladder cancer (MIBC)
    Meeting Abstract

    Balar, A. V.; Iyer, G.; Apolo, A. B.; Regazzi, A. M.; Garcia-Grossman, I. R.; Pendse, D.; Ostrovnaya, I.; Chou, J. F.; Bochner, B.; Dalbagni, G.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save